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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S122media. Neither fatty acids nor TNFa were cytotoxic. The increase in COX2
gene expression of cultured chondrocytes in response to TNFa was coun-
teracted by DHA (p<0.05) and oleic acid (p<0.05). MMP1 expression was
also increased in response to TNFa and this effect was counteracted by
oleic acid (p<0.05) and palmitic acid (p<0.05). GAG release by cartilage
explants was decreased when cultured in oleic acid (p<0.05). Gene
expression of MMP3, MMP13 and ADAMTS4 in cell cultures and NO
production by cartilage explants did not signiﬁcantly change in response to
any fatty acid. Exposure of chondrocytes and explants to linoleic acid (n-6)
in absence or presence of TNFa did not inﬂuence any of the parameters
measured.
Conclusions: DHA (n-3), oleic acid (n-9), and palmitic acid (saturated) are
able to counteract some of the effects induced by TNFa in cartilage
explants or chondrocyte cultures. This was already known for DHA, but
reported for the ﬁrst time for oleic acid and palmitic acid.
Since fatty acids inﬂuence inﬂammation and degradation of cartilage, they
can be regarded potential therapeutic targets in OA prevention and
treatment.
Figure1. The effect of fatty acids on COX2 gene expression in chondrocytes
in absence or presence of 10 ng/ml TNFa (n¼6, from 2 donors).
ĂAcknowledgment: This study was performed within the framework of the Dutch Top Institute
Pharma project #T1-213.
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THROMBIN AND PLASMIN INDUCED PROTEOGLYCAN RELEASE IN
HUMAN CARTILAGE IS PAR-DEPENDENT
L. Nieuwenhuizen, R.E. Schutgens, G. Roosendaal, S.C. Mastbergen,
D.H. Biesma, F.P. Lafeber. Univ. Med. Ctr. Utrecht, Utrecht, Netherlands
Purpose: Osteoarthritis (OA) and Rheumatoid Arthrisis (RA) are charac-
terized by degradation of the cartilage. Proteases of the coagulation
cascade and the ﬁbrinolytic system, such as thrombin and plasmin, are
elevated in both plasma and synovial ﬂuid of OA and RA patients and are
able to induce cartilage degradation. Cross-talking between coagulation
and inﬂammation is mediated by protease-activated-receptors (PARs),
which are expressed at increased level in OA and RA cartilage. These
receptors are activated through cleavage by serine proteases, such as
thrombin and plasmin. RNA interference is a process inwhich genes can be
silenced sequence-speciﬁc. This can be invoked by transfection of tissue/
cells with small interfering RNA (siRNA). Our aimwas to study whether the
thrombin- and plasmin-induced cartilage damage in human cartilage was
PAR-dependent.
Methods: Full-thickness OA human articular cartilage tissue was
obtained during total knee surgery. Slices of cartilage were cut asepti-
cally from the articular surface. Within 1 hour of dissection the sliceswere cut into square pieces, weighed aseptically (range, 5.0 to 15.0 mg)
and each sample was individually put into culture. Cartilage was
cultured for 4 days in the presence of different concentrations thrombin
(10, 30, or 100nM), or plasmin (10, 30, or 100nM). In addition, cartilage
was transfected with PAR1-4 small interfering RNA (600nM) or control
siRNA (600nM), and cultured with thrombin (100nM) or plasmin
(100nM). Cartilage matrix turnover, in terms of proteoglycan release,
was determined at day 4. To investigate the silencing effect of the siRNA
transfection, cartilage RNA was extracted and PAR1-4 mRNA expression
was analyzed with RT-PCR.
Results: Thrombin and plasmin increased proteoglycan release in human
cartilage in a dose-dependent and statistically signiﬁcant manner (500%
for thrombin at 100nM; 217% for plasmin at 100nM). Thrombin- and
plasmin-induced proteoglycan release was statistically signiﬁcant reduced
with PAR1-4 siRNA (60% for thrombin at 100nM; 54% for plasmin at
100nM). Control siRNA failed to reduce thrombin- and plasmin-induced
proteoglycan release. Transfectionwith PAR1-4 siRNA resulted in complete
suppression of PAR1-4 mRNA expression, whereas no effect of control
siRNA on PAR1-4 mRNA expression was noted.
Conclusions: These results demonstrate for the ﬁrst time that thrombin
and plasmin-induced proteoglycan release in human cartilage is PAR-
dependent and offer promise for the use of siRNA as a new strategy for
therapeutic intervention in OA and RA.
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BONE SIALOPROTEIN : A KEY MEDIATOR OF THE ANGIOGENIC ACTIVITY
OF HYPERTROPHIC OSTEOARTHRITIC CHONDROCYTES
L. Pesesse 1, C. Sanchez 1, C. Baudouin 2, P. Msika 2, Y. Henrotin 1. 1Univ. of
Liege, Liege, Belgium; 2 Laboratoires ExpanSci., IRD Direction, Epernon, France
Purpose: Hypertrophic differentiation of chondrocytes in osteoarthritis
(OA) is a pathological process leading to vascularization and mineraliza-
tion of the cartilage. The pathogenesis of OA is thought to reiterate changes
that occur during endochondral ossiﬁcation in which angiogenesis is
required to initiate chondrocyte hypertrophic differentiation. We previ-
ously demonstrated that Bone Sialoprotein (BSP) production is associated
with chondrocyte hypertrophy and the severity of osteoarthritic lesions. In
this work, we investigated the impact of hypertrophic differentiation on
the chondrocytes capacity to promote vascularization. We also speculated
that BSP is a key mediator of cartilage vascularization.
Methods: In alginate beads, OA chondrocytes cultured in the presence of
serum undergo hypertrophic differentiation in long-term culture. Using
this model, we tested the effects of hypertrophic chondrocytes condi-
tioned medium after 24 hours serum deprivation on the invasion and
migration of endothelial cells using two different models : the real-time
follow-up of the cells performed with the xCELLigence system (Roche)
and high-end microscopic analysis of living endothelial cells in a wound
healing assay. We also studied BSP gene expression (by RT-PCR)
and production (by western blot) during chondrocyte hypertrophic
differentiation. The effects of IL-1b (170 pg/ml) and TNFa (25 ng/ml) were
tested on the synthesis of BSP by hypertrophic chondrocytes. These
cytokines were added to the culture medium before (day 7) or after
(day 21) hypertrophic phenotype was reached. Finally, the effect of
increased concentration of recombinant BSP (25 ng/ml to 400 ng/ml) on
the production of a proangiogenic factor, interleukin-8 (IL8) and an
anti-angiogenic factor, thrombospondin-1 (TSP1) was studied by
immunoassays.
Results: Hypertrophic OA chondrocytes conditionned medium showed
a higher stimulating effect on endothelial cells migration and invasion
than serum-containing medium (positive control). We demonstrated that
BSP gene expression and protein productionwere associated with markers
of hypertrophy collagen type 10 (COL X), alkaline phosphatase (AP),
nucleoside triphosphate pyrophosphohydrolase (NTPPPH) in OA but this
association was not observed in normal chondrocyte cultures. IL-1b or
TNFa in the culture medium decreased gene expression of BSP when
added at day 7 or at day 21 (p<0.05). In the same manner, both cytokines
